Promoting equitable patient representation in therapeutic clinical trials by accounting for population disease burden
- PMID: 40148374
- PMCID: PMC11950398
- DOI: 10.1038/s41598-025-91174-x
Promoting equitable patient representation in therapeutic clinical trials by accounting for population disease burden
Conflict of interest statement
Declarations. Competing interests: The authors report no competing interests.
Comment on
-
Demographic recruitment bias of adults in United States randomized clinical trials by disease categories between 2008 to 2019: a systematic review and meta-analysis.Sci Rep. 2023 Jan 2;13(1):42. doi: 10.1038/s41598-022-23664-1. Sci Rep. 2023. PMID: 36593228 Free PMC article.
References
-
- Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. Federal Register. https://www.federalregister.gov/documents/2016/09/30/2016-23672/standard... (2016).
-
- Taparra, K. Pacific islanders searching for inclusion in medicine. JAMA Health Forum2, e210153 (2021). - PubMed
-
- Duma, N. et al. Representation of minorities and women in oncology clinical trials: Review of the past 14 years. J. Oncol. Pract.14, e1–e10 (2018). - PubMed
Publication types
LinkOut - more resources
Full Text Sources